name:-0.14679193496704
name:-0.055339097976685
name:-0.062826871871948
Chen; Minhua Patent Filings

Chen; Minhua

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Minhua.The latest application filed is for "crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof".

Company Profile
61.48.65
  • Chen; Minhua - Jiangsu CN
  • CHEN; Minhua - Suzhou CN
  • - Suzhou CN
  • Chen; Minhua - Scotch Plains NJ
  • CHEN; Minhua - Beijing CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Crystal forms of crisaborole in free form and preparation method and use thereof
Grant 11,447,506 - Chen , et al. September 20, 2
2022-09-20
Crystalline Form Of Valbenazine Ditosylate, Processes For Preparation Thereof And Use Thereof
App 20220267326 - CHEN; Minhua ;   et al.
2022-08-25
Crystal Form Of Hypoxia-inducible Factor-prolyl Hydroxylase Inhibitor
App 20220251044 - CHEN; Minhua ;   et al.
2022-08-11
Crystal Form Of Upadacitinib, Preparation Method Therefor, And Use Thereof
App 20220204519 - CHEN; Minhua ;   et al.
2022-06-30
Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof
Grant 11,339,158 - Chen , et al. May 24, 2
2022-05-24
Upadacitinib Crystal Form And Preparation Method Therefor And Use Thereof
App 20210380596 - CHEN; Minhua ;   et al.
2021-12-09
Crystalline Forms Of Gft-505, Processes For Preparation And Use Thereof
App 20210363101 - Chen; Minhua ;   et al.
2021-11-25
Crystal Form Of Tafamidis And Preparation Method Therefor And Use Thereof
App 20210363116 - CHEN; Minhua ;   et al.
2021-11-25
Cabozantinib Malate Crystal Form, Preparation Method And Use Thereof
App 20210332014 - Chen; Minhua ;   et al.
2021-10-28
Crystalline form of EB-1020, processes for preparation and use thereof
Grant 11,149,004 - Chen , et al. October 19, 2
2021-10-19
Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof
Grant 11,136,347 - Chen , et al. October 5, 2
2021-10-05
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof
App 20210300893 - Chen; Minhua ;   et al.
2021-09-30
Crystalline Forms Of Ozanimod And Processes For Preparation Thereof
App 20210292287 - Chen; Minhua ;   et al.
2021-09-23
Crystal form of Baricitinib and preparation method thereof
Grant 11,124,517 - Chen , et al. September 21, 2
2021-09-21
Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof
Grant 11,117,871 - Chen , et al. September 14, 2
2021-09-14
Crystalline form of ozanimod hydrochloride, and processes for preparation thereof
Grant 11,117,876 - Chen , et al. September 14, 2
2021-09-14
Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof
Grant 11,111,223 - Chen , et al. September 7, 2
2021-09-07
Crystal form of acalabrutinib and preparation method and use thereof
Grant 11,091,494 - Chen , et al. August 17, 2
2021-08-17
Crystalline Forms Of Gsk1278863, Preparation Method And Pharmaceutical Use Thereof
App 20210230124 - Chen; Minhua ;   et al.
2021-07-29
Crystalline forms of ARN-509, preparation method and use thereof
Grant 11,066,384 - Chen , et al. July 20, 2
2021-07-20
Crystalline Form Of Eb-1020, Processes For Preparation And Use Thereof
App 20210179558 - Chen; Minhua ;   et al.
2021-06-17
Crystalline Forms Of Selective Progesterone Receptor Modulator, Processes For Preparation Thereof
App 20210171568 - Chen; Minhua ;   et al.
2021-06-10
Crystalline forms of ozanimod and processes for preparation thereof
Grant 11,028,060 - Chen , et al. June 8, 2
2021-06-08
Crystal Form Of Baricitinib And Preparation Method Thereof
App 20210147423 - CHEN; Minhua ;   et al.
2021-05-20
Crystalline Forms Of A Fatty Acid Bile Acid Conjugate, Preparation Method Thereof And Use Thereof
App 20210147471 - Chen; Minhua ;   et al.
2021-05-20
New Crystal Form Of Acalbrutinib, Preparation Method Therefor And Use Thereof
App 20210087195 - Chen; Minhua ;   et al.
2021-03-25
A Crystalline Form Of Valbenazine Ditosylate, Processes For Preparation Thereof And Use Thereof
App 20210078993 - Chen; Minhua ;   et al.
2021-03-18
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof
App 20210017148 - Chen; Minhua ;   et al.
2021-01-21
Crystal Forms of Crisaborole In Free Form And Preparation Method And Use Thereof
App 20210002307 - Chen; Minhua ;   et al.
2021-01-07
Crystal form of ozanimod hydrochloride and processes for preparation therefor
Grant 10,882,830 - Chen , et al. January 5, 2
2021-01-05
Novel Crystal Form Of Acalabrutinib And Preparation Method And Use Thereof
App 20200347069 - Chen; Minhua ;   et al.
2020-11-05
Crystalline Form Of Ozanimod Hydrochloride, And Processes For Preparation Thereof
App 20200339524 - Chen; Minhua ;   et al.
2020-10-29
Crystal forms of an androgen receptor antagonist, preparation method and use thereof
Grant 10,815,221 - Chen , et al. October 27, 2
2020-10-27
Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereof
Grant 10,815,232 - Chen , et al. October 27, 2
2020-10-27
Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereof
Grant 10,759,779 - Chen , et al. Sep
2020-09-01
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof
App 20200270226 - Chen; Minhua ;   et al.
2020-08-27
Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof
Grant 10,752,595 - Chen , et al. A
2020-08-25
Crystal Form Of Androgen Receptor Antagonist Medication, Preparation Method Therefor, And Use
App 20200239450 - CHEN; Minhua ;   et al.
2020-07-30
Crystal Forms Of Ozanimod And Preparation Method Therefor
App 20200216404 - CHEN; Minhua ;   et al.
2020-07-09
Crystalline Forms Of Gsk1278863, Preparation Method And Pharmaceutical Use Thereof
App 20200216399 - Chen; Minhua ;   et al.
2020-07-09
Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereof
Grant 10,703,724 - Chen , et al.
2020-07-07
Crystalline Form Of Orexin Receptor Antagonist, Processes For Preparation Thereof And Use Thereof
App 20200190060 - Chen; Minhua ;   et al.
2020-06-18
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof
App 20200157065 - Chen; Minhua ;   et al.
2020-05-21
Crystalline forms of JAK1-selective inhibitor, processes for preparation and use thereof
Grant 10,633,376 - Chen , et al.
2020-04-28
Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof
Grant 10,626,135 - Chen , et al.
2020-04-21
Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof
Grant 10,604,521 - Chen , et al.
2020-03-31
Galunisertib crystalline form, preparation method thereof and use thereof
Grant 10,604,528 - Chen , et al.
2020-03-31
Novel Crystalline Forms Of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] Amino} Acetic Acid And Processes For Preparation T
App 20200095203 - Chen; Minhua ;   et al.
2020-03-26
Galunisertib crystalline form, preparation method thereof and use thereof
Grant 10577372 -
2020-03-03
Crystalline form E of tafamidis meglumine, process for preparation and use thereof
Grant 10,577,334 - Chen , et al.
2020-03-03
Crystalline form of lenvantinib mesylate and process of preparation thereof
Grant 10,562,855 - Chen , et al. Feb
2020-02-18
Crystalline forms of AP26113, and preparation method thereof
Grant 10,544,129 - Chen , et al. Ja
2020-01-28
Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
Grant 10,508,087 - Chen , et al. Dec
2019-12-17
Crystalline forms of selective S1P1 receptor modulator and preparation method thereof
Grant 10,487,064 - Chen , et al. Nov
2019-11-26
Crystalline Forms Of Viral-protein Inhibitor Drug Vx-787, Processes For Preparation Thereof And Use Thereof
App 20190352303 - Chen; Minhua ;   et al.
2019-11-21
Crystalline Forms Of Selective S1p1 Receptor Modulator And Preparation Method Thereof
App 20190345120 - Chen; Minhua ;   et al.
2019-11-14
Crystalline forms of (6-(1H-indazol-6-yl)-N-[4-(4-(4-morpholinyl)phenyl]imidazo[1,2-A]pyrazin-- 8-amine) methanesulfonate
Grant 10,472,369 - Chen , et al. Nov
2019-11-12
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof
App 20190337908 - CHEN; Minhua ;   et al.
2019-11-07
Crystalline Forms Of A Bromodomain And Extraterminal Protein Inhibitor Drug, Processes For Preparation Thereof, And Use Thereof
App 20190330161 - Chen; Minhua ;   et al.
2019-10-31
Crystalline Forms Of Ap26113, And Preparation Method Thereof
App 20190322646 - Chen; Minhua ;   et al.
2019-10-24
Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium salt
Grant 10,442,775 - Chen , et al. Oc
2019-10-15
Crystal forms of NBI-98854, preparation method and use thereof
Grant 10,442,800 - Chen , et al. Oc
2019-10-15
Crystalline Forms Of Plx3397 Hydrochloride, Processes For Preparation And Use Thereof
App 20190256510 - Chen; Minhua ;   et al.
2019-08-22
Crystal Form Of Ozanimod Hydrochloride, And Preparation Method Therefor
App 20190248755 - CHEN; Minhua ;   et al.
2019-08-15
Crystal form of JAK inhibitor and preparation method thereof
Grant 10,377,757 - Chen , et al. A
2019-08-13
Galunisertib Crystalline Form, Preparation Method Thereof And Use Thereof
App 20190241572 - Chen; Minhua ;   et al.
2019-08-08
Novel Crystalline Form of Lenvantinib Mesylate and Process of Preparation Thereof
App 20190218184 - CHEN; Minhua ;   et al.
2019-07-18
Crystal Forms Of Nbi-98854, Preparation Method And Use Thereof
App 20190218209 - Chen; Minhua ;   et al.
2019-07-18
Crystalline forms of lesinurad and its sodium salt
Grant 10,351,536 - Chen , et al. July 16, 2
2019-07-16
Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof
Grant 10,323,035 - Chen , et al.
2019-06-18
Crystalline Forms Of Jak1-selective Inhibitor, Processes For Preparation And Use Thereof
App 20190177314 - Chen; Minhua ;   et al.
2019-06-13
New Crystal Form Of Sodium-glucose Co-transporter Inhibitor Processes For Preparation And Use Thereof
App 20190169219 - CHEN; Minhua ;   et al.
2019-06-06
Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof
Grant 10,308,641 - Chen , et al.
2019-06-04
Crystalline form A of obeticholic acid and preparation method thereof
Grant 10,273,262 - Chen , et al.
2019-04-30
Crystalline Form E Of Tafamidis Meglumine, Process For Preparation And Use Thereof
App 20190119226 - Chen; Minhua ;   et al.
2019-04-25
Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4'-(trifluo- romethoxy) [1,1'-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
Grant 10,266,523 - Chen , et al.
2019-04-23
Hydrochloride Salt Crystal Of Drug For Treating Or Preventing Jak-associated Disease And Preparation Method Thereof
App 20190100519 - CHEN; Minhua ;   et al.
2019-04-04
Crystal form of lenvatinib methanesulfonate salt and preparation method thereof
Grant 10,246,418 - Chen , et al.
2019-04-02
Crystal form of neratinib maleate and preparation method therefor
Grant 10,246,437 - Chen , et al.
2019-04-02
Crystalline Form A Of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide Dihydrochloride And Preparation Method Thereof
App 20190092756 - Chen; Minhua ;   et al.
2019-03-28
Crystalline form of AHU377, preparation method and use thereof
Grant 10,233,144 - Chen , et al.
2019-03-19
New Crystalline Forms Of (6-(1h-indazol-6-yl)-n-[4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-a- Mine) Methanesulfonate
App 20190055255 - Chen; Minhua ;   et al.
2019-02-21
Crystalline form alpha of IPI-145 and preparation method thereof
Grant 10,196,395 - Chen , et al. Fe
2019-02-05
Preparation Method For Eutectic Hydrate Crystal Form Ii Of Ahu-377 And Diovan Trisodium Salt
App 20180354916 - CHEN; Minhua ;   et al.
2018-12-13
Preparation method of crystalline form a of PCI-32765
Grant 10,138,239 - Chen , et al. Nov
2018-11-27
Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
Grant 10,138,250 - Chen , et al. Nov
2018-11-27
Salt of Pyrrolo[2,3-D]pyrimidine Compound and Novel Polymorph of Salt
App 20180282342 - Chen; Minhua ;   et al.
2018-10-04
New Crystal Form Of Neratinib Maleate And Preparation Method Therefor
App 20180265495 - CHEN; Minhua ;   et al.
2018-09-20
Novel Crystal Form Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane Formamido)-3-methylpyridine-2-yl)benzoic Acid And Preparation Method Thereof
App 20180230136 - CHEN; Minhua ;   et al.
2018-08-16
Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof
App 20180201589 - CHEN; Minhua ;   et al.
2018-07-19
Crystaline Forms Of N-[6-(cis-2,6-dimethylmorpholine -4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy) [1,1'-biphenyl]-3-methanamide Monophosphate, And Process Of Preparation Thereof
App 20180170919 - CHEN; Minhua ;   et al.
2018-06-21
Crystalline Form A Of Obeticholic Acid And Preparation Method Thereof
App 20180170958 - CHEN; Minhua ;   et al.
2018-06-21
Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt
Grant 9,994,579 - Chen , et al. June 12, 2
2018-06-12
New Crystal Form Of Lenvatinib Methanesulfonate Salt And Preparation Method Thereof
App 20180155291 - CHEN; Minhua ;   et al.
2018-06-07
Salts and co-crystals of lesinurad
Grant 9,969,701 - Chen , et al. May 15, 2
2018-05-15
Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
Grant 9,957,240 - Chen , et al. May 1, 2
2018-05-01
Crystalline Form Of Ahu377, Preparation Method And Use Thereof
App 20180086695 - CHEN; Minhua ;   et al.
2018-03-29
Crystalline Form Alpha Of Ipi-145 And Preparation Method Thereof
App 20180072733 - CHEN; Minhua ;   et al.
2018-03-15
Preparation Method Of Pci-32765 Crystal Form A
App 20180065958 - CHEN; Minhua ;   et al.
2018-03-08
Cdk Inhibitor, Eutectic Crystal Of Mek Inhibitor, And Preparation Method Therefor
App 20180057498 - CHEN; Minhua ;   et al.
2018-03-01
Controlled Multi-needle Point Expanding Radiofrequency Ablation Electrode Needle
App 20180049802 - YANG; Wei ;   et al.
2018-02-22
Crystal Form Of Jak Inhibitor And Preparation Method Thereof
App 20180044342 - CHEN; Minhua ;   et al.
2018-02-15
Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof
App 20170362189 - CHEN; Minhua ;   et al.
2017-12-21
Salt of Pyrrolo[2,3-D]pyrimidine Compound and Novel Polymorph of Salt
App 20170342075 - Chen; Minhua ;   et al.
2017-11-30
Crystalline form I of ibrutinib
Grant 9,751,889 - Chen , et al. September 5, 2
2017-09-05
Crystalline Form I Of Ibrutinib
App 20170002009 - CHEN; Minhua ;   et al.
2017-01-05
Novel Salts And Co-crystals Of Lesinurad
App 20160347722 - CHEN; Minhua ;   et al.
2016-12-01
Crystalline Forms Of Lesinurad And Its Sodium Salt
App 20160297778 - CHEN; Minhua ;   et al.
2016-10-13
CRYSTALLINE FORMS B, C, and D OF CANAGLIFLOZIN
App 20160280731 - CHEN; Minhua ;   et al.
2016-09-29
Crystalline hydrochloride salts of c-Met kinase inhibitors
Grant 8,674,105 - Avalle , et al. March 18, 2
2014-03-18
Crystalline Hydrochloride Salts Of C-met Kinase Inhibitors
App 20120184744 - Avalle; Paolo ;   et al.
2012-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed